Rheumatology Journals
Rheumatology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Rheumatology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
rheumatoid arthritis  rheumatoid arthritis
lupus  lupus
polymyalgia  polymyalgia
sjogrens  sjogrens
fibromyalgia  fibromyalgia
amyloidosis  amyloidosis
vasculitis  vasculitis
urate  urate
raynauds  raynauds
myositis  myositis
 
Sponsor
MDLinx Email Article

To email this article, enter your own "From Email" address,
the recipient's "To Email" address, and click the "Send Email" button.
You may send to up to 5 email addresses.
*From Email:  
*To Email:  
To Email:  
To Email:  
To Email:  
To Email:  
The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis
Elkayam O et al. – Study reports that influenza virus vaccine generated a good humoral response in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients treated with infliximab.

Methods
  • An assessment of the effect of the timing of vaccination in relation to administration of infliximab on the efficacy and safety of influenza vaccine in pts with RA and AS
  • 38 pts treated with infliximab at a mean dosage of 3 mg/kg:
    • 20 RA pts; 18 AS pts
    • 23 RA controls treated with DMARDs other than anti-TNF-α and
    • 17 healthy controls
  • Pts treated with infliximab were divided into 2 groups:
    • 22 were vaccinated on the day of administration of infliximab
    • 16 received the vaccine 3 wks after infliximab
  • Baseline and 4- to 6-wk clinical assessment of disease activity included ESR and CRP for all pts, the DAS28 for RA pts, and BASDAI for AS pts
  • Hemagglutination inhibition (HI) Abs were tested by a standard WHO procedure
  • Response was defined as ≥4-fold rise in HI Abs 4 to 6 wks after vaccination, or seroconversion in pts with a nonprotective baseline level of Abs
  • Geometric mean titers (GMT) were calculated to assess the immunity of the whole group
Results
  • At baseline, RA pts and controls had similar occurrence of protective levels of HI Abs and GMT
  • AS pts had lower levels reflecting lower rates of previous vaccination
  • 4 wks after vaccination, a similar increase in GMT for each antigen was observed in all groups except in the RA-infliximab group, vaccinated 3 wks after admin. of infliximab, in whom the increase in GMT was not significant for H1N1
  • AS pts demonstrated an increase in GMT, independently of the time of vaccination
  • The percentage of responders was similar in all groups
  • Response was not affected by variables such as age, gender, MTX, or prednisone use
  • Parameters of disease activity remained unchanged
  • No AEs other than injection site pain were recorded
[more...]
Sponsor

Read a Different Specialty

General Rheumatology Articles
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

General Rheumatology Articles
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.